March 17, 2017 / 6:28 PM / a year ago

BUZZ-U.S. STOCKS ON THE MOVE-Adobe, Tiffany, Amgen, Editas

* Eikon search string for individual stock moves: STXBZ

* The Day Ahead newsletter:

* The Morning News Call newsletter:

U.S. stocks were little changed on Friday as a slide in Amgen dragged down the healthcare sector, offsetting gains in technology shares.

The Dow Jones Industrial Average was down 0.03 percent at 20,928.05, the S&P 500 was down 0.05 percent at 2,380.15 and the Nasdaq Composite was down 0.08 percent at 5,896.197.

** ADOBE SYSTEMS INC, $129.09, +5.51 pct

The company reported better-than-expected first-quarter revenue and profit as demand for Creative Cloud package of software tools, which includes Photoshop, continued to rise.

** TIFFANY & CO, $93.28, +3.67 pct

The jeweler reported better-than-expected fourth-quarter profit, helped by strong demand for its jewelry in Japan and China, as well as price hikes and lower costs.

** ARBUTUS BIOPHARMA CORP, $3.23, +13.16 pct

The RNAi drug developer on Thursday said it has licensed its drug delivery technology to Alexion Pharmaceuticals Inc for exclusive use in one of the company’s rare disease drug programs.

** CALADRIUS BIOSCIENCES INC, $6.04, +18.43 pct

The drugmaker reported a narrower-than-expected fourth-quarter loss.

** EDITAS MEDICINE INC, $22.97, -7.79 pct

The gene-editing company offered 4 million shares at $22.50, a 9.7 percent discount to stock’s Thursday last sale.

** GALENA BIOPHARMA INC, $0.68, +9.65 pct

The immunotherapy developer provided promising early-stage data on its immunotherapy vaccine, GALE-301, for the prevention of recurrence of ovarian and endometrial cancer in patients.


The cancer drug developer said it would merge with privately held Molecular Templates.

** VIVINT SOLAR INC, $2.93, +6.36 pct

The solar panel maker posted a smaller-than-expected loss for the third straight quarter.

** AMGEN INC, $168.15, -6.64 pct

Analysts said data from a large study testing the impact of Amgen’s cholesterol drug on the heart was weaker than expected.

** VERITIV CORP, $51.50, -12.49 pct

The print and paper distributor’s biggest shareholder UWW Holdings LLC, affiliate of PE firm Bain Capital, cuts its stake.


ValueAct Capital raised its stake in the Canadian drugmaker, in a move that could provide a confidence boost to the drug company three days after its largest shareholder sold out of the stock.


The property and casualty insurer delayed filing its annual report. (Compiled by Akankshita Mukhopadhyay in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below